We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-7.72%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$157M
AUM Growth
+$31.7M
Cap. Flow
+$45.5M
Cap. Flow %
28.95%
Top 10 Hldgs %
45.06%
Holding
108
New
39
Increased
16
Reduced
23
Closed
22

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$8.9M
2
MA icon
Mastercard
MA
+$8.7M
3
FISV
Fiserv Inc
FISV
+$8.43M
4
PYPL icon
PayPal
PYPL
+$6.75M
5
FIS icon
Fidelity National Information Services
FIS
+$4.01M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$5.13M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$4.35M
3
NUAN
Nuance Communications, Inc.
NUAN
+$3.59M
4
CONE
CyrusOne Inc Common Stock
CONE
+$3.47M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$1.99M

Sector Composition

Rank Sector Weight
1 Healthcare 44.39%
2 Technology 25.46%
3 Financials 19.54%
4 Consumer Discretionary 2.88%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHWK
101
Whitehawk Therapeutics
WHWK
$266M
– –
-40,549
Closed -$979K
KNTE
102
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-46,264
Closed -$820K
FMTX
103
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-40,612
Closed -$578K
CONE
104
DELISTED
CyrusOne Inc Common Stock
CONE
– –
-38,700
Closed -$3.47M
ARNA
105
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-21,433
Closed -$1.99M
NUAN
106
DELISTED
Nuance Communications, Inc.
NUAN
– –
-64,841
Closed -$3.59M
INFO
107
DELISTED
IHS Markit Ltd. Common Shares
INFO
– –
-32,743
Closed -$4.35M
XLNX
108
DELISTED
Xilinx Inc
XLNX
– –
-24,173
Closed -$5.13M
1 2 3 4
5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, HighVista Strategies held 108 positions worth $157M, up 25% from $126M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

HighVista Strategies deployed $45.5M of net new capital in Q1 2022, opening 39 new positions and adding to 16 existing holdings. Its largest new stake was Visa: 41,135 shares worth $9.12M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 53% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Xenon Pharmaceuticals, an estimated $1.05M trimmed.

  • HighVista Strategies's largest Q1 2022 buy was Visa: 41,135 shares worth $9.12M.
  • HighVista Strategies added most to Protagonist Therapeutics in Q1 2022, an estimated $1.72M increase.
  • HighVista Strategies's biggest Q1 2022 reduction was Xenon Pharmaceuticals, cutting an estimated $1.05M.
  • HighVista Strategies fully exited Xilinx Inc in Q1 2022, selling an estimated $5.13M.
  • HighVista Strategies's ten largest holdings make up 45% of its $157M portfolio in Q1 2022.
  • HighVista Strategies opened 39 new positions and closed 22 in Q1 2022.
  • HighVista Strategies's portfolio value rose 25% quarter-over-quarter to $157M.

Based on HighVista Strategies's 13F filing for Q1 2022, filed 16 May 2022.